Human Immunodeficiency Virus/Hepatitis C Virus Coinfection in Spain: Prevalence and Patient Characteristics
Juan Berenguer(Instituto de Salud Carlos III), Carmen Quereda(Instituto Cajal), Víctor Hontañón, Rocío Montejano, María Jesús Vivancos(Hospital Universitario Ramón y Cajal), Francisco Arnalich(Hospital Universitario Son Espases), Marisa Montes(Hospital La Paz Institute for Health Research), Ignacio de los Santos, José Ramón Arribas(Hospital Universitario La Paz), V. Moreno, Eulalia Valencia, Antonio Rivero(University of Southern California), Inmaculada Jarrín(Instituto de Salud Carlos III), Marı́a Jesús Pérez-Elı́as(Hospital Universitario Ramón y Cajal), Ignacio Valero(Instituto de Salud Carlos III), Luz Martín‐Carbonero, Francisco Tejerina(Instituto de Salud Carlos III), Cristina Díez(Hospital General Universitario Gregorio Marañón), Marta Montero, B. Padilla(Universitat Autònoma de Barcelona), Arturo Artero(Hospital Universitario Doctor Peset), Peré Domingo(Hospital de Sant Pau), Juan González‐García(Hospital Universitario La Paz), Manuel Márquez(Hospital Clínico Universitario Virgen de la Victoria), Ana Moreno(Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna "Bruno Ubertini"), Santiago Moreno(Universidad El Bosque), J. Marta Moreno(Hospital Universitario Miguel Servet), José L. Casado(Instituto Cajal), José Antonio Iribarren(Biogipuzkoa Health Research Institute), María Jesús Téllez(Hospital Clínico San Carlos), Pilar Miralles(Hospital General Universitario Gregorio Marañón), Manel Crespo(Hospital Sant Pau i Santa Tecla), F Parras, J. C. Lopez, A. Carrero, Teresa Aldámiz, Francisca Cuenca, Leire Pérez‐Latorre, M.J. Núñez(Hospital Universitario La Paz), José Ignacio Bernardino(Hospital Universitario La Paz)
Cited by 42
Related Papers
Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV
|New England Journal of Medicine|2006|886
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
|The Lancet HIV|2023|506
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel
|AIDS|2002|443
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
|Clinical Microbiology and Infection|2020|423
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort
|The Lancet HIV|2020|396